麻豆传媒

Dr. Daadi is an expert in regulated translational research and has developed therapeutic neural stem cell lines (NSC) for clinical use in Parkinson’s disease, stroke, and to target brain tumors in both industrial and academic settings. He discovered a novel technique of engineering these stem cell lines from pluripotent human embryonic stem cells and continues to develop this therapeutic cell line for clinical use. Dr. Daadi came to Texas Biomed in 2014 and is the team leader for the SNPRC Regenerative Medicine and Aging research unit. Results from his studies are the foundation of translational research and help to repair diseased or injured brain through transplantation of highly purified NSCs and stimulation of internal repair mechanisms.

Dr. Scott Rodeo is an attending orthopedic surgeon specializing in sports medicine and director of the Center for Regenerative Medicine at HSS. He is a professor of Orthopedic Surgery at Weill Cornell Medical College and co-chief emeritus of the Sports Medicine Institute at HSS. 

Dr. Rodeo specializes in sports medicine injuries of the knee, shoulder, ankle and elbow. He has specific expertise in complex knee reconstruction (including meniscus transplantation, cartilage resurfacing, osteotomy, and ligament reconstruction), treatment of shoulder instability and rotator cuff tendon repair. His research focuses on the basic biology of tendon and ligament healing, meniscal allograft transplantation and rotator cuff repair.

Dr. Rodeo cares for elite, professional and everyday athletes. He was named head team team physician of the New York Giants Football Team in 2015. In 2004 and 2008, he served as Team Physician for USA Swimming and returned to this position for the London 2012 Olympic Games. A former competitive swimmer himself, Dr. Rodeo continues to work with USA Swimming and various swimming programs where he helps to promote injury prevention and treats injured swimmers of all ages. 

Marian Hettiaratchi and members of her lab work to develop protein delivery vehicles for regenerative medicine by integrating cutting-edge techniques in protein engineering, polymer chemistry, and computational modeling to design versatile, clinically-relevant biomaterials. Hettiaratchi is a recipient of an NIH R21 Trailblazer Award for her project, 鈥淎 Directed Evolution Approach to Affinity-Based Protein Delivery.鈥�  She was a postdoctoral fellow at the University of Toronto after receiving her PhD in biomedical engineering from Georgia Institute of Technology and Emory University. She joined the UO faculty in 2020 and holds an affiliate appointment at Oregon Health & Science University. 

Dr Coopman鈥檚 research focuses on how we can manufacture cell-based therapies for regenerative medicine.

She is particularly interested in developing scalable systems for stem cell growth and improving methods of cell preservation so that we can produce clinically relevant numbers of cells that are also effective and safe.

Owen graduated with an MRes in tissue engineering and regenerative medicine from the University of Manchester. He subsequently completed a PhD at the University of Birmingham that sought to compare the efficacy of stem cells isolated from adipose, bone marrow and dental pulp for the regeneration of mineralised tissues.

In 2016 Owen was awarded a competitive EPSRC E-TERM fellowship in collaboration with the University of Birmingham where he worked as an honorary visiting fellow in the School of Chemical Engineering with Professor Liam Grover. During his fellowship he pioneered the application of cell-derived nanoparticles, termed extracellular vesicles (EVs), for musculoskeletal therapies.

In April 2018 Owen was appointed as a lecturer in Molecular and Regenerative Biomedicine under the Loughborough Excellence 100 scheme. He was promoted to Senior Lecturer in 2021.